ART-001

N/A

Report date: 2025/05/27 16:02:11

Base Information

Drug NameART-001
Drug Alias NameART-001ART001
ClassificationCell and gene therapy > Gene therapy > Gene editingCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionTransthyretin modulators
TargetsTransthyretin
Therapy Area/IndicationsTransthyretin amyloidosisCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesRuizheng Gene (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College HospitalRuizheng Gene (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsTransthyretin amyloidosisCardiomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A